Compare LNSR & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNSR | AEI |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.8M | 132.7M |
| IPO Year | N/A | N/A |
| Metric | LNSR | AEI |
|---|---|---|
| Price | $12.56 | $2.90 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 30.5K | ★ 42.4K |
| Earning Date | 02-26-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,141,000.00 | $12,108,028.00 |
| Revenue This Year | $19.55 | N/A |
| Revenue Next Year | $35.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.02 | N/A |
| 52 Week Low | $8.25 | $0.70 |
| 52 Week High | $17.31 | $4.55 |
| Indicator | LNSR | AEI |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 47.81 |
| Support Level | $11.86 | $2.82 |
| Resistance Level | $12.09 | $3.18 |
| Average True Range (ATR) | 0.31 | 0.34 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 99.61 | 9.25 |
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.